Quality of life in age-related macular degeneration: A review of available vision-specific psychometric tools

Quality of Life Research

Volumn 17, Issue 4, 2008, Pages 559-574

  Finger, Robert P ^a   Fleckenstein, Monika ^a   Holz, Frank G ^a   Scholl, Hendrik P N ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Age related macular degeneration (AMD); Psychometric and non psychometric properties; Psychometric tools; Quality criteria; Quality of life

Indexed keywords

IMPACT OF VISION IMPAIREMENT PROFILE; MACULAR DISEASE DEPENDENT QUALITY OF LIFE QUESTIONNAIRE; MEDICAL LITERATURE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; PUBLICATION; QUALITY OF LIFE; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; VALIDATION STUDY; VISUAL FUNCTION QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; AGE FACTORS; ALGORITHMS; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MACULAR DEGENERATION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; VISION TESTS;

EID: 43049180291     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-008-9327-4     Document Type: Review

References (86)

1. Fine S. L., Berger J. W., Maguire M. G., & Ho A. C. (2000). Age-related macular degeneration. The New England Journal of Medicine 342, 483-492.
2. Trautner C., Haastert B., Richter B., Berger M., & Giani G. (2003). Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Investigative Ophthalmology & Visual Science, 44, 1031-1034.
3. Birk T., Hickl S., Wahl H. W., Miller D., Kammerer A., Holz F., Becker S., & Volcker H. E. (2004). Development and pilot evaluation of a psychosocial intervention program for patients with age-related macular degeneration. Gerontologist, 44, 836-843.
4. de Jong P. T. (2006). Age-related macular degeneration. The New England Journal of Medicine, 355, 1474-1485.
5. Holz F. G., Pauleikhoff D., Klein R., & Bird A. C. (2004). Pathogenesis of lesions in late age-related macular disease. American Journal of Ophthalmology, 137, 504-510.
6. Eter N., Krohne T. U., & Holz F. G. (2006). New pharmacologic approaches to therapy for age-related macular degeneration. BioDrugs, 20, 167-179.
7. The Age-related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, 119, 1417-1436.
8. Slakter J. S., & Stur M. (2005). Quality of life in patients with age-related macular degeneration: Impact of the condition and benefits of treatment. Survey of Ophthalmology, 50, 263-273.
9. Brody B. L., Gamst A. C., Williams R. A., Smith A. R., Lau P. W., Dolnak D., Rapaport M. H., Kaplan R. M., & Brown S. I. (2001). Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology, 108, 1893-1900, discussion 1900-1891.
10. Brody B. L., Williams R. A., Thomas R. G., Kaplan R. M., Chu R. M., & Brown S. I. (1999). Age-related macular degeneration: A randomized clinical trial of a self-management intervention. Annals of Behavioural Medicine, 21, 322-329.
11. Williams R. A., Brody B. L., Thomas R. G., Kaplan R. M., & Brown S. I. (1998). The psychosocial impact of macular degeneration. Archives of Ophthalmology, 116, 514-520.
12. O'Shaughnessy J. A., Wittes R. E., Burke G., Friedman M. A., Johnson J. R., Niederhuber J. E., Rothenberg M. L., Woodcock J., Chabner B. A., & Temple R. (1991). Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. Journal of Clinical Oncology, 9, 2225-2232.
13. Committee for Medicinal Products for Human Use (CHMP). (2005). Reflection Paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medicinal products. In: EMEA, London.
14. Chassany O., Sagnier P., Marquis P., Fullerton S., & Aaronson N. (2002). Patient-reported outcomes: The example of health-related quality of life-A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209-238.
15. Cahill M. T., Banks A. D., Stinnett S. S., & Toth C. A. (2005). Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology, 112, 152-158.
16. Margolis M. K., Coyne K., Kennedy-Martin T., Baker T., Schein O., & Revicki D. A. (2002). Vision-specific instruments for the assessment of health-related quality of life and visual functioning: A literature review. Pharmacoeconomics, 20, 791-812.
17. de Boer M. R., Moll A. C., de Vet H. C., Terwee C. B., Volker-Dieben H. J., & van Rens G. H. (2004). Psychometric properties of vision-related quality of life questionnaires: A systematic review. Ophthalmic & Physiological Optics, 24, 257-273.
18. Mangione C. M., Phillips R. S., Seddon J. M., Lawrence M. G., Cook E. F., Dailey R., & Goldman L. (1992). Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Medical Care, 30, 1111-1126.
19. Pesudovs K., & Coster D. J. (1998). An instrument for assessment of subjective visual disability in cataract patients. The British Journal of Ophthalmology, 82, 617-624.
20. Pesudovs K., Garamendi E., Keeves J. P., & Elliott D. B. (2003). The activities of daily vision scale for cataract surgery outcomes: Re-evaluating validity with Rasch analysis. Investigative Ophthalmology & Visual Science 44, 2892-2899.
21. Hart P. M., Chakravarthy U., Stevenson M. R., & Jamison J. Q. (1999). A vision specific functional index for use in patients with age related macular degeneration. The British Journal of Ophthalmology, 83, 1115-1120.
22. Hart P. M., Stevenson M. R., Montgomery A. M., Muldrew K. A., & Chakravarthy U. (2005). Further validation of the daily living tasks dependent on vision: Identification of domains. The British Journal of Ophthalmology, 89, 1127-1130.
23. Schmier J. K., Halpern M. T., & Covert D. (2006). Validation of the daily living tasks dependent on vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration. Ophthalmic Epidemiology, 13, 137-143.
24. McClure M. E., Hart P. M., Jackson A. J., Stevenson M. R., & Chakravarthy U. (2000). Macular degeneration: Do conventional measurements of impaired visual function equate with visual disability? The British Journal of Ophthalmology, 84, 244-250.
25. Lamoureux E. L., Pallant J. F., Pesudovs K., Rees G., Hassell J. B., & Keeffe J. E. (2007). The impact of vision impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and rasch analysis. Investigative Ophthalmology & Visual Science, 48, 1001-1006.
26. Lamoureux E. L., Pallant J. F., Pesudovs K., Hassell J. B., & Keeffe J. E. (2006). The impact of vision impairment questionnaire: An evaluation of its measurement properties using Rasch analysis. Investigative Ophthalmology & Visual Science, 47, 4732-4741.
27. Hassell J. B., Weih L. M., & Keeffe J. E. (2000). A measure of handicap for low vision rehabilitation: The impact of vision impairment profile. Clinical & Experiment Ophthalmology, 28, 156-161.
28. Mitchell J., & Bradley C. (2004). Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Quality of Life Research, 13, 1163-1175.
29. Mitchell J., Wolffsohn J. S., Woodcock A., Anderson S. J., McMillan C. V., Ffytche T., Rubinstein M., Amoaku W., & Bradley C. (2005). +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health and Quality of Life Outcomes, 3, 25.
30. Mangione C. M., Lee P. P., Gutierrez P. R., Spritzer K., Berry S., & Hays R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119, 1050-1058.
31. Miskala P. H., Hawkins B. S., Mangione C. M., Bass E. B., Bressler N. M., Dong L. M., Marsh M. J., & McCaffrey L. D. (2003). Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: Findings in patients with subfoveal choroidal neovascularization-SST Report No. 1. Archives of Ophthalmology, 121, 531-539.
32. Mangione C. M., Lee P. P., Pitts J., Gutierrez P., Berry S., & Hays R. D. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Archives of Ophthalmology, 116, 1496-1504.
33. Mangione C. M., Berry S., Spritzer K., Janz N. K., Klein R., Owsley C., & Lee P. P. (1998). Identifying the content area for the 51-item national eye institute visual function questionnaire: Results from focus groups with visually impaired persons. Archives of Ophthalmology, 116, 227-233.
34. Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., & Damiano A. M., et al. (1994). The VF-14. An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112, 630-638.
35. Linder M., Chang T. S., Scott I. U., Hay D., Chambers K., Sibley L. M., & Weis E. (1999). Validity of the visual function index (VF-14) in patients with retinal disease. Archives of Ophthalmology, 117, 1611-1616.
36. Riusala A., Sarna S., & Immonen I. (2003). Visual function index (VF-14) in exudative age-related macular degeneration of long duration. American Journal of Ophthalmology, 135, 206-212.
37. Cassard S. D., Patrick D. L., Damiano A. M., Legro M. W., Tielsch J. M., Diener-West M., Schein O. D., Javitt J. C., Bass E. B., & Steinberg E. P. (1995). Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Archives of Ophthalmology, 113, 1508-1513.
38. Lindblad A. S., & Clemons T. E. (2005). Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Archives of Ophthalmology, 123, 1207-1214.
39. Clemons T. E., Chew E. Y., Bressler S. B., & McBee W. (2003). National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Archives of Ophthalmology, 121, 211-217.
40. Suzukamo Y., Oshika T., Yuzawa M., Tokuda Y., Tomidokoro A., Oki K., Mangione C. M., Green J., & Fukuhara S. (2005). Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health and Quality of Life Outcomes, 3, 65.
41. Toprak A. B., Eser E., Guler C., Baser F. E., & Mayali H. (2005). Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiology, 12, 259-269.
42. Rossi G. C., Milano G., & Tinelli C. (2003). The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: Translation, validity, and reliability. Journal of Glaucoma, 12, 213-220.
43. Hudson H. L., Lane S. S., Heier J. S., Stulting R. D., Singerman L., Lichter P. R., Sternberg P., & Chang D. F. (2006). Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-Year results. Ophthalmology, 113, 1987-2001.
44. Fuhs A., Dasch B., Behrens T., Meister A., Krause K., Pauleikhoff D., & Hense H. W. (2005). Visual function and quality of life in patients with age-related maculopathy: Results of the Munster Age and Retina Study (MARS). Klin Monatsbl Augenheilkd, 222, 649-654.
45. Cahill M. T., Stinnett S. S., Banks A. D., Freedman S. F., & Toth C. A. (2005). Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology, 112, 144-151.
46. Miskala P. H., Bass E. B., Bressler N. M., Childs A. L., Hawkins B. S., Mangione C. M., & Marsh M. J. (2004). Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Quality-of-life findings: SST report no. 12. Ophthalmology, 111, 1981-1992.
47. Childs A. L., Bressler N. M., Bass E. B., Hawkins B. S., Mangione C. M., Marsh M. J., & Miskala P. H. (2004). Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings: SST report no. 14. Ophthalmology, 111, 2007-2014.
48. Scilley K., DeCarlo D. K., Wells J., & Owsley C. (2004). Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services. Ophthalmic Epidemiology, 11, 131-146.
49. Dong L. M., Childs A. L., Mangione C. M., Bass E. B., Bressler N. M., Hawkins B. S., Marsh M. J., Miskala P., Jaffee H. A., & McCaffrey L. A. (2004). Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. American Journal of Ophthalmology, 138, 91-108.
50. Maguire M. (2004). Baseline characteristics, the 25-item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology, 111, 1307-1316.
51. Varma R., Paz S. H., Azen S. P., Klein R., Globe D., Torres M., Shufelt C., & Preston-Martin S. (2004). The Los Angeles Latino Eye Study: Design, methods, and baseline data. Ophthalmology, 111, 1121-1131.
52. DeCarlo D. K., Scilley K., Wells J., & Owsley C. (2003). Driving habits and health-related quality of life in patients with age-related maculopathy. Optom Vis Sci, 80, 207-213.
53. Berdeaux G. H., Nordmann J. P., Colin E., & Arnould B. (2005). Vision-related quality of life in patients suffering from age-related macular degeneration. American Journal of Ophthalmology, 139, 271-279.
54. Brody B. L., Roch-Levecq A. C., Thomas R. G., Kaplan R. M., & Brown S. I. (2005). Self-management of age-related macular degeneration at the 6-month follow-up: A randomized controlled trial. Archives of Ophthalmology, 123, 46-53.
55. Brody B. L., Roch-Levecq A. C., Gamst A. C., Maclean K., Kaplan R. M., & Brown S. I. (2002). Self-management of age-related macular degeneration and quality of life: A randomized controlled trial. Archives of Ophthalmology, 120, 1477-1483.
56. Miskala P. H., Bressler N. M., & Meinert C. L. (2004). Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Archives of Ophthalmology, 122, 758-766.
57. Bansback N., Czoski-Murray C., Carlton J., Lewis G., Hughes L., Espallargues M., Brand C., & Brazier J. (2007). Determinants of health related quality of life and health state utility in patients with age related macular degeneration: The association of contrast sensitivity and visual acuity. Quality of Life Research, 16, 533-543.
58. Pham T. Q., Cugati S., Rochtchina E., Mitchell P., Maloof A., & Wang J. J. (2007). Age-related maculopathy and cataract surgery outcomes: Visual acuity and health-related quality of life. Eye, 21, 324-330.
59. Hewitt A. W., Jeganathan V. S., Kidd J. E., Pesudovs K., & Verma N. (2006). Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Archive for Clinical and Experimental Ophthalmology, 244, 972-977.
60. Armbrecht A. M., Aspinall P. A., & Dhillon B. (2004). A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. The British Journal of Ophthalmology 88, 1270-1273.
61. Armbrecht A. M., Findlay C., Aspinall P. A., Hill A. R., & Dhillon B. (2003). Cataract surgery in patients with age-related macular degeneration: One-year outcomes. Journal of Cataract and Refractive Surgery, 29, 686-693.
62. Mackenzie P. J., Chang T. S., Scott I. U., Linder M., Hay D., Feuer W. J., & Chambers K. (2002). Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology, 109, 720-729.
63. Armbrecht A. M., Findlay C., Kaushal S., Aspinall P., Hill A. R., & Dhillon B. (2000). Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. The British Journal of Ophthalmology, 84, 1343-1348.
64. Scott I. U., Smiddy W. E., Schiffman J., Feuer W. J., Pappas & C. J. (1999). Quality of life of low-vison patients and the impact of low-vision services. American Journal of Ophthalmology, 128, 54-62.
65. Weih L. M., Hassell J. B., & Keeffe J. E. (2002). Assessment of the impact of vision impairment. Investigative Ophthalmology & Visual Science, 43, 927-935.
66. Keeffe J. E., McCarty C. A., Hassell J. B., & Gilbert A. G. (1999). Description and measurement of handicap caused by vision impairment. Australian and New Zealand Journal of Ophthalmology, 27, 184-186.
67. Hassell J. B., Lamoureux E. L., & Keeffe J. E. (2006). Impact of age related macular degeneration on quality of life. The British Journal of Ophthalmology, 90, 593-596.
68. Lamoureux E. L., Hassell J. B., & Keeffe J. E. (2004). The determinants of participation in activities of daily living in people with impaired vision. American Journal of Ophthalmology, 137, 265-270.
69. Stevenson M. R., Hart P. M., Chakravarthy U., Mackenzie G., Bird A. C., Owens S. L., Chisholm I. H., Hall V., Houston R. F., McCulloch D. W., & Plowman N. (2005). Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. The British Journal of Ophthalmology, 89, 1045-1051.
70. Stevenson M. R., Hart P. M., Montgomery A. M., McCulloch D. W., & Chakravarthy U. (2004). Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. The British Journal of Ophthalmology, 88, 1125-1130.
71. Mangione C. M., Gutierrez P. R., Lowe G., Orav E. J., & Seddon J. M. (1999). Influence of age-related maculopathy on visual functioning and health-related quality of life. American Journal of Ophthalmology, 128, 45-53.
72. Lane S. S., Kuppermann B. D., Fine I. H., Hamill M. B., Gordon J. F., Chuck R. S., Hoffman R. S., Packer M., & Koch D. D. (2004). A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. American Journal of Ophthalmology, 137, 993-1001.
73. Hazel C. A., Petre K. L., Armstrong R. A., Benson M. T., & Frost N. A. (2000). Visual function and subjective quality of life compared in subjects with acquired macular disease. Investigative Ophthalmology & Visual Science, 41, 1309-1315.
74. Reeves B. C., Harper R. A., & Russell W. B. (2004). Enhanced low vision rehabilitation for people with age related macular degeneration: A randomised controlled trial. The British Journal of Ophthalmology, 88, 1443-1449.
75. Krummenauer F., Braun M., & Dick H. B. (2005). Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration. European Journal of Ophthalmology, 15, 74-80.
76. Lundstrom M., Brege K. G., Floren I., Lundh B., Stenevi U., & Thorburn W. (2002). Cataract surgery and quality of life in patients with age related macular degeneration. The British Journal of Ophthalmology, 86, 1330-1335.
77. Carta A., Braccio L., Belpoliti M., Soliani L., Sartore F., Gandolfi S. A., & Maraini G. (1998). Self-assessment of the quality of vision: Association of questionnaire score with objective clinical tests. Current Eye Research, 17, 506-511.
78. Gupta S. K., Viswanath K., Thulasiraj R. D., Murthy G. V., Lamping D. L., Smith S. C., Donoghue M., & Fletcher A. E. (2005). The development of the Indian vision function questionnaire: Field testing and psychometric evaluation. The British Journal of Ophthalmology, 89, 621-627.
79. Alonso J., Espallargues M., Andersen T. F., Cassard S. D., Dunn E., Bernth-Petersen P., Norregaard J. C., Black C., Steinberg E. P., & Anderson G. F. (1997). International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology, 104, 799-807.
80. Crabtree H. L., Hildreth A. J., O'Connell J. E., Phelan P. S., Allen D., & Gray C. S. (1999). Measuring visual symptoms in British cataract patients: The cataract symptom scale. The British Journal of Ophthalmology, 83, 519-523.
81. Fitzpatrick R., Davey C., Buxton M. J., & Jones D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2, i, iv-1, 74.
82. Pallant J. F., & Tennant A. (2007). An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). The British Journal of Clinical Psychology, 46, 1-18.
83. Massof R. W., & Fletcher D. C. (2001). Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Research, 41, 397-413.
84. Langelaan M., van Nispen R. M., Knol D. L., Moll A. C., de Boer M. R., Wouters B., & van Rens G. H. (2007). Visual Functioning Questionnaire: Reevaluation of psychometric properties for a group of working-age adults. Optometry and Vision Science 84, 775-784.
85. Denny F., Marshall A. H., Stevenson M. R., Hart P. M., & Chakravarthy U. (2007). Rasch analysis of the daily living tasks dependent on vision (DLTV). Investigative Ophthalmology & Visual Science, 48, 1976-1982.
86. Velozo C. A., Lai J. S., Mallinson T., & Hauselman E. (2000). Maintaining instrument quality while reducing items: Application of Rasch analysis to a self-report of visual function. Journal of Outcome Measurement, 4, 667-680.